Search research articles
Contact Us
Filters
Showing results (231-240 of 368) with videos related to
Page
of 37
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
September 7, 2015
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies
Moisés A Calderón, Jörg Kleine-Tebbe, Allan Linneberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
Carmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
The World Allergy Organization Journal
|
September 19, 2024
Who is at-risk for severe anaphylaxis in France?
Luciana Kase Tanno, Pham Thao Van Luong, Megane Dieval, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
May 28, 2015
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey
Moises A Calderon, Linda Cox, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2014
Respiratory allergy caused by house dust mites: What do we really know?
Moisés A Calderón, Allan Linneberg, Jörg Kleine-Tebbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 6, 2018
Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies
Guillaume Pouessel, Paul J Turner, Margitta Worm, et al.
The Lancet Regional Health. Europe
|
November 5, 2024
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
The Lancet Regional Health. Europe
|
May 6, 2024
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 11, 2025
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study
Philippe Devillier, Pascal Demoly, Jean-François Bergmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 18, 2025
Development of a Risk-Stratification Tool for Nonsteroidal Anti-Inflammatory Drug Hypersensitivity on a Large Cohort
Ileana-Maria Ghiordanescu, Iuliana Ciocănea-Teodorescu, Rik Schrijvers, et al.
Page
of 37
Search research articles
Search
Showing results (231-240 of 368) with videos related to
Sort By:
Page
of 37
The Journal of Allergy and Clinical Immunology. in Practice
|
September 7, 2015
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies
Moisés A Calderón, Jörg Kleine-Tebbe, Allan Linneberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
Carmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
The World Allergy Organization Journal
|
September 19, 2024
Who is at-risk for severe anaphylaxis in France?
Luciana Kase Tanno, Pham Thao Van Luong, Megane Dieval, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
May 28, 2015
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey
Moises A Calderon, Linda Cox, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2014
Respiratory allergy caused by house dust mites: What do we really know?
Moisés A Calderón, Allan Linneberg, Jörg Kleine-Tebbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 6, 2018
Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies
Guillaume Pouessel, Paul J Turner, Margitta Worm, et al.
The Lancet Regional Health. Europe
|
November 5, 2024
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
The Lancet Regional Health. Europe
|
May 6, 2024
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 11, 2025
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study
Philippe Devillier, Pascal Demoly, Jean-François Bergmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 18, 2025
Development of a Risk-Stratification Tool for Nonsteroidal Anti-Inflammatory Drug Hypersensitivity on a Large Cohort
Ileana-Maria Ghiordanescu, Iuliana Ciocănea-Teodorescu, Rik Schrijvers, et al.
Page
of 37